Trogarzo
Ibalizumab-uiyk injection is used together with other medicines for the treatment of the infection caused by the human immunodeficiency virus (HIV) in patients who have received anti-HIV medicines that did not work well, who are resistant to many antiretroviral medicines, or who are failing their current antiretroviral treatment. HIV is the virus that causes acquired immune deficiency syndrome (AIDS). Ibalizumab-uiyk injection will not cure or prevent HIV infection or AIDS, however, it helps keep HIV from reproducing and appears to slow down the destruction of the immune system. This may help delay the development of problems that usually result from AIDS or HIV disease. Ibalizumab-uiyk injection will not keep you from spreading HIV to other people. People who receive this medicine may continue to have the problems usually related to AIDS or HIV disease. This medicine is to be given only by or under the direct supervision of your doctor. This product is available in the following dosage forms:
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered: Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully. Appropriate studies have not been performed on the relationship of age to the effects of ibalizumab-uiyk injection in the pediatric population. Safety and efficacy have not been established. Appropriate studies on the relationship of age to the effects of ibalizumab-uiyk have not been performed in the geriatric population. There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive. Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
A nurse or other trained health professional will give you this medicine in a hospital or medical facility. It is given through a needle placed into one of your veins. This medicine may be given slowly, so the needle will have to stay in place for at least 15 to 30 minutes (IV infusion). This medicine may also be given into your vein for at least 30 to 90 seconds (IV push). You will receive this medicine every 2 weeks. Your doctor may want you stay for at least 15 minutes to 1 hour after receiving the injection to check for any unwanted effects. This medicine comes with a patient information leaflet. Read and follow these instructions carefully. Ask your doctor if you have any questions.
Disclaimer: August is a health information platform and its responses don't constitute medical advise. Always consult with a licenced medical professional near you before making any changes.